Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Cholangiocarcinoma 2Bile Duct Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 1Lung Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1

Interventions

Gemcitabine 13Oxaliplatin 9Capecitabine 6lenvatinib 5apatinib 5Cisplatin 5tislelizumab 4Surgical Procedures, Operative 4Radiofrequency Ablation 4Neoadjuvant Therapy 4Fluorouracil 4toripalimab 3sintilimab 3Radiotherapy 3Leucovorin 3Irinotecan 3regorafenib 2pembrolizumab 2durvalumab 2camrelizumab 2Stents 2Photochemotherapy 2Immunotherapy 2Hepatectomy 2Folfox protocol 2Everolimus 2Drug Therapy 2Cholangiopancreatography, Endoscopic Retrograde 2Blood Specimen Collection 21-phenyl-3,3-dimethyltriazene 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Cholangiocarcinoma × 1-phenyl-3,3-dimethyltriazene × Clear all
NCT05519319 2023-02-21

Safety and Efficacy of PDT vs RFA vs PDT+RFA for the Treatment of Extrahepatic Cholangiocarcinoma

First People's Hospital of Hangzhou

Phase NA Unknown
70 enrolled
Gastrointestinal

Bile Duct Neoplasms, Cholangiocarcinoma

NCT01755013 2017-02-20

Photodynamic Therapy (PDT) for Palliation of Cholangiocarcinoma

Weill Medical College of Cornell University

Phase 2/3 Unknown
55 enrolled
Gastrointestinal

Bile Duct Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡